Classification
- Anatomical main groupNNervous system
- Therapeutic subgroupN05
- Pharmacological subgroupN05B
- Chemical subgroupN05BA
- Chemical substanceN05BA08Bromazepam
Where it is registered
Each register with its number of medicines and a few of them.
Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Health Canada · 24 medicines
AEMPS · 13 medicines
ALIMS · 11 medicines
HALMED · 9 medicines
MS · 4 medicines · Historical list
SFDA · 3 medicines · Historical list
CBG-MEB · 2 medicines
HSA · 2 medicines
Every register, a page at a time. Strengths and packs are on each medicine’s page.
13 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| BROMAZEPAM PENSA 3 mg CAPSULAS EFG | Spain | 3 mg | cápsula dura | Marketed | Towa Pharmaceutical S.A. |
| BROMAZEPAM KERN PHARMA 3 mg CAPSULAS EFG | Spain | 3 mg | cápsula dura | Marketed | Kern Pharma S.L. |
| BROMAZEPAM NORMON 3 mg CAPSULAS DURAS EFG | Spain | 3 mg | cápsula dura | Marketed | Laboratorios Normon S.A. |
| BROMAZEPAM NORMON 6 mg CAPSULAS DURAS EFG | Spain | 6 mg | cápsula dura | Marketed | Laboratorios Normon S.A. |
| BROMAZEPAM KERN PHARMA 1,5 mg CAPSULAS EFG | Spain | 1,5 mg | cápsula dura | Marketed | Kern Pharma S.L. |
| BROMAZEPAM NORMON 1,5 mg CAPSULAS DURAS EFG | Spain | 1,5 mg | cápsula dura | Marketed | Laboratorios Normon S.A. |
| Bromazepam Tarbis 6 MG Capsulas Duras Efg | Spain | 6 mg | cápsula dura | Authorised | Tarbis Farma S.L. |
| BROMAZEPAM PENSA 1,5 mg CAPSULAS EFG | Spain | 1,5 mg | cápsula dura | Suspended | Towa Pharmaceutical S.A. |
| Bromazepam Tarbis 3 MG Capsulas Duras Efg | Spain | 3 mg | cápsula dura | Withdrawn | Tarbis Farma S.L. |
| BROMAZEPAM STADA 1,5 mg CAPSULAS DURAS EFG | Spain | 1,5 mg | cápsula dura | Withdrawn | Laboratorio Stada S.L. |
| Bromazepam Tarbis 1,5 MG Capsulas Duras Efg | Spain | 1,5 mg | cápsula dura | Withdrawn | Tarbis Farma S.L. |
| LEXATIN 1,5 mg CAPSULAS DURAS | Spain | 1,5 mg | cápsula dura | Marketed | Cheplapharm Arzneimittel Gmbh |
| LEXATIN 3 mg CAPSULAS DURAS | Spain | 3 mg | cápsula dura | Marketed | Cheplapharm Arzneimittel Gmbh |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, HALMED, Health Canada, HSA, MS, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.